Fat Tissue Injection Supports Cartilage Health for Two Years
Igor Borić, Damir Hudetz, Eduard Rod, Željko Jeleč, Trpimir Vrdoljak, Andrea Skelin, Ozren Polašek, Mihovil Plečko, Irena Trbojević-Akmačić, Gordan Lauc, Dragan Primorac · Genes · 2019
Study Tracks Cartilage Building Blocks Using Advanced MRI
This Croatian study followed patients with knee osteoarthritis for 24 months after receiving a single injection of their own processed fat tissue (Lipogems®). Researchers used a specialized MRI technique called dGEMRIC to measure glycosaminoglycans (GAGs)—essential molecules that keep cartilage healthy and cushioned. GAGs normally decrease as osteoarthritis progresses, so tracking them reveals whether treatment is helping preserve or rebuild cartilage.
The study enrolled 17 patients with moderate to severe knee osteoarthritis. Ten patients (18 knees total) completed the full two-year follow-up. Three patients left the study because they needed knee replacement surgery. The remaining four did not complete all required visits.
Over Half of Cartilage Measurements Showed Improvement
The results were encouraging. More than half of the cartilage measurements showed meaningful increases in GAG content at 24 months. This finding is particularly significant because GAG levels typically decline over time in people with osteoarthritis. Instead of the expected worsening, many patients showed improved cartilage health.
The dGEMRIC technique works by tracking how contrast dye moves through cartilage. Healthy cartilage with abundant GAGs repels the dye, while damaged cartilage absorbs more of it. Higher readings indicate healthier cartilage with better cushioning ability.
Single Injection Provided Long-Lasting Benefits
Patients received just one injection of micro-fragmented adipose tissue (MFAT)—specially processed fat from their own body. The fat was collected through a minimally invasive lipoaspiration procedure, then processed and injected into the affected knee. No repeat treatments were needed during the study period.
Researchers measured outcomes at baseline, three months, six months, 12 months, and 24 months. Pain levels were tracked using the Visual Analog Scale (VAS), a standard tool where patients rate their pain from zero to ten.
Treatment May Stimulate Cartilage Repair Processes
The study builds on the researchers' earlier 12-month findings, which first suggested that MFAT injection could positively affect cartilage composition. This extended follow-up confirms that benefits can persist for at least two years.
The micro-fragmented fat tissue contains:
Pericytes: Helper cells that support healing around blood vessels
Mesenchymal stem cells (MSCs): Regenerative cells that may help repair damaged tissue
Natural growth factors: Proteins that encourage tissue healing
Because the treatment uses your own tissue (called autologous), there is no risk of rejection or disease transmission from donors.
What This Means for Your Treatment Decision
This study provides objective evidence that MFAT injection can positively influence cartilage health in osteoarthritic knees. Unlike treatments that only mask symptoms, this approach appears to support actual cartilage repair processes at the molecular level.
Key points to consider:
The specialized MRI technique detected real changes in cartilage composition
Benefits lasted throughout the two-year study period
A single injection was sufficient for the observed improvements
Three of 17 patients still required knee replacement, indicating the treatment may not work for everyone
The study involved patients with advanced osteoarthritis (Kellgren-Lawrence grades III and IV), suggesting that even those with significant joint damage may benefit. However, the small number of patients who completed the full follow-up (10 of 17) means larger studies would strengthen these findings.
If you are considering Lipogems® for knee osteoarthritis, this research suggests the treatment may do more than reduce pain—it may help protect and improve your remaining cartilage. Discuss with your doctor whether your osteoarthritis stage and overall health make you a good candidate for this regenerative approach.
---
Source: Borić et al., Genes, 2019.
Original Publication
A 24-Month Follow-Up Study of the Effect of Intra-Articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis
Igor Borić, Damir Hudetz, Eduard Rod, Željko Jeleč, Trpimir Vrdoljak, Andrea Skelin, Ozren Polašek, Mihovil Plečko, Irena Trbojević-Akmačić, Gordan Lauc, Dragan Primorac · Genes · 2019
Osteoarthritis (OA) is a widely prevalent disease worldwide that requires evaluation by multimodality imaging assessment. This prospective, non-randomized, interventional, single-center, open-label clinical trial evaluated the effect of intra-articular injection of autologous microfragmented adipose tissue on knee OA over 24 months. The study was conducted from January 2016 to April 2018 and enrolled 17 patients with 32 knees assessed at 12-month follow-up, though only 10 patients with 18 knees completed the 24-month follow-up. Surgical intervention involved lipoaspiration, tissue processing, and intra-articular injection of microfragmented adipose tissue into affected knees. Patients were assessed using visual analog scale (VAS) and delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) at baseline, three, six, 12, and 24 months post-treatment. The dGEMRIC technique assessed glycosaminoglycan (GAG) content in cartilage through infiltration of anionic, negatively-charged contrast gadopentetate dimeglumine (Gd-DTPA²⁻). Results demonstrated that cartilage GAG content significantly increased in specific areas of treated knee joints. Over half of measurements showed relevant improvement 24 months after injection, contrasting the expected GAG decrease during natural disease progression. These findings suggest that single intra-articular injection of autologous microfragmented adipose tissue improves GAG content on a significant scale in knee OA patients.